TSLA
Tesla
-- 418.300 NVDA
NVIDIA
-- 136.020 MSTR
MicroStrategy
-- 299.750 FFIE
Faraday Future Intelligent Electric Inc.
-- 4.0088 RGTI
Rigetti Computing
-- 17.0200 
NEWS
Spyre Therapeutics Announces Pricing of $200 Million Public Offering of Common Stock
Spyre Therapeutics (NASDAQ: SYRE) has priced its public offering of 7,275,000 common stock shares at $27.50 per share, expecting to raise $200.0 million in gross proceeds. The clinical-stage biotech company, focused on IBD treatments, has granted underwriters a 30-day option to purchase up to additional 1,091,250 shares. The offering, managed by Jefferies, Goldman Sachs, Evercore Group, and Guggenheim Securities, is expected to close around November 20, 2024.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment